Voyager Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Voyager Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Voyager Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.78M, a 39.4% increase year-over-year.
  • Voyager Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $17.7M, a 86% increase year-over-year.
  • Voyager Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $11.7M, a 164% increase from 2022.
  • Voyager Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $4.45M, a 83.6% increase from 2021.
  • Voyager Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $2.42M, a 74.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.7M +$7.28M +164% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $4.45M +$2.02M +83.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $2.42M -$6.94M -74.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $9.36M +$1.28M +15.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 $8.08M +$5.46M +208% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $2.63M +$1.46M +125% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $1.17M +$7K +0.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $1.16M +$10.6M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$9.42M -$7.47M -383% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 -$1.95M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.